Clinical Trials Logo

Diabetic Neuropathies clinical trials

View clinical trials related to Diabetic Neuropathies.

Filter by:

NCT ID: NCT03847129 Completed - Diabetes Mellitus Clinical Trials

Assessments and Interventions for Hand Neuropathy in DM

Start date: August 20, 2015
Phase: N/A
Study type: Interventional

This study is to investigate the effects of task-based biofeedback training compared with home-based programs on sensorimotor function and quality of life for diabetic patients with neuropathic hands. The investigators hypothesize that the task-based biofeedback training might have significant effectiveness for restoration of sensory function, precision pinch performance, hand dexterity and life quality for patients with diabetic neuropathy.

NCT ID: NCT03769675 Completed - Clinical trials for Painful Diabetic Neuropathy

Quantitative Assessment of Painful Diabetic Peripheral Neuropathy After High Frequency Spinal Cord Stimulation

Start date: November 20, 2018
Phase: N/A
Study type: Interventional

Will participants with painful lower extremity diabetic peripheral neuropathy (DPN) that are treated with high frequency spinal cord stimulation (HF10 SCS) have improvements in lower extremity peripheral nerve function?

NCT ID: NCT03755960 Completed - Diabetic Neuropathy Clinical Trials

ACUpuncture in Diabetic Peripheral Neuropathy

ACUDPN
Start date: March 2, 2019
Phase: N/A
Study type: Interventional

Multicentric,randomized, two-armed confirmatory trial on the effectiveness of acupuncture in patients with symptomatic peripheral diabetic neuropathy compared to routine care.

NCT ID: NCT03755934 Completed - Clinical trials for Painful Diabetic Neuropathy

Efficacy and Safety of MEDI7352 in Subjects With Painful Diabetic Neuropathy

Start date: November 19, 2018
Phase: Phase 2
Study type: Interventional

This is a study investigating the effect of MEDI7352 on chronic pain in patients with painful diabetic neuropathy. The study incudes a screening period of up to 45 days and a 12-week treatment period during which MEDI7352 or placebo will be administered intravenously (IV) on 6 occasions, with each dose separated by 14 days. There will be a 6-week follow-up period. Subjects will randomly be assigned to double-blind treatment with one of 4 dose levels of MEDI7352 or placebo

NCT ID: NCT03749642 Completed - Clinical trials for Painful Diabetic Neuropathy

Trazodone/Gabapentin Fixed Dose Combination Products in Painful Diabetic Neuropathy

Start date: November 22, 2018
Phase: Phase 2
Study type: Interventional

The primary objective of the study is to collect preliminary information on the effect of three doses of trazodone/gabapentin FDC products on pain intensity in patients with painful diabetic neuropathy after 8-week treatment period.

NCT ID: NCT03712475 Completed - Fibromyalgia Clinical Trials

Pharmacokinetics of Two Formulation of Pregabalin

Start date: January 19, 2018
Phase: Phase 4
Study type: Interventional

A Randomized, Single-Dose, Parallel-Group Study to Evaluate the Pharmacokinetic Profiles of Two Formulations of Pregabalin after Oral Administration in Healthy Volunteers under Fasting Conditions

NCT ID: NCT03700580 Completed - Diabetic Foot Clinical Trials

Clinical Trial Using the Proteolytic Fraction P1G10 From V. Cundinamarcensis to Heal Diabetic Foot Ulcer

P1G10
Start date: August 15, 2012
Phase: Phase 2
Study type: Interventional

The aim of the study was to investigate the role of the proteolytic fraction from Vasconcellea cundinamarcensis, designated as P1G10, on healing of chronic foot ulcers in neuropathic patients diagnosed with diabetes type 2. Fifty patients were enrolled in a prospective, randomized, double-blind trial, to verify the efficacy and safety of a topical dressing containing 0.1% P1G10, versus a Hydrogel (positive control) protocol currently applied at the Health Center to treat this condition. Upon completion of the intervention, the outcome evaluated the number of patients attaining full epithelization (100%), or at least 80% healing in both arms (P1G10 versus Hydrogel). Statistical analysis compared the endpoint data on each group to assess the significance of differences.

NCT ID: NCT03687840 Completed - Clinical trials for Diabetic Polyneuropathy

Spatio-Temporal Gait Parameters and Gait Symmetry In Diabetic Lower Extremity Burn Injury.

Start date: February 14, 2017
Phase: N/A
Study type: Interventional

This study evaluated the spatio-temporal gait parameters and gait symmetry in individuals with lower extremity burn injury due to diabetic polyneuropathy. Study group consisted of 14 subjects with unilateral lower extremity burn injuries due to diabetic polyneuropathy and control group consisted of 14 subjects with only diabetic polyneuropathy.

NCT ID: NCT03676595 Completed - Clinical trials for Diabetic Neuropathy Peripheral

Video Game Balance Training for Patients With Diabetic Neuropathy

Start date: November 20, 2013
Phase: N/A
Study type: Interventional

This study evaluated the effects of interactive video game-based exercise (IVGB) on balance in diabetic patients with peripheral neuropathy. Twenty-four patients were randomly assigned to two groups (12 participants per group). Group A received IVGB training for the first 6 weeks, with no exercise in the subsequent 6 weeks. Group B had no exercise for the first 6 weeks and then underwent IVGB training in the subsequent 6 weeks. Both subjective and objective measures were used to determine whether IVGB exercise improves balance function.

NCT ID: NCT03664921 Completed - Neuropathic Pain Clinical Trials

Omnitram Safety and Efficacy in the Treatment of Diabetic Neuropathy

Start date: November 15, 2018
Phase: Phase 2
Study type: Interventional

This study evaluates the analgesic effect of Omnitram for the treatment of painful diabetic neuropathy. Each subject with diabetic neuropathy will be treated for four weeks with Omnitram and for four weeks with placebo. The order of the Omnitram and placebo treatment will be random.